Journal article icon

Journal article

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.

Abstract:

BACKGROUND: A considerable proportion of patients with asthma remain uncontrolled or symptomatic despite treatment with a high dose of inhaled glucocorticosteroids (ICSs) and long-acting β2-agonists (LABAs). Tiotropium Respimat(®) added to usual care improves lung function, asthma control, and the frequency of non-severe and severe exacerbations, in a population of adult asthma patients who are uncontrolled despite treatment with ICS/LABA. OBJECTIVE: This study estimated the cost effectivenes...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1007/s40258-014-0107-8

Authors


Willson, J More by this author
Bateman, ED More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine
Krivasi, T More by this author
Expand authors...
Publisher:
Springer International Publishing Publisher's website
Journal:
Applied health economics and health policy Journal website
Volume:
12
Issue:
4
Pages:
447-459
Publication date:
2014
DOI:
EISSN:
1179-1896
ISSN:
1175-5652
URN:
uuid:799a5dd4-0732-43cd-bc93-689ce013baa5
Source identifiers:
472131
Local pid:
pubs:472131
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP